secwatch.observer — SEC 8-K summary
======================================

Issuer:     3D SYSTEMS CORP (DDD)
CIK:        0000910638
Form:       8-K
Filed at:   2023-12-14T23:59:59+00:00
Accession:  0001193125-23-295484
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

3D Systems appoints new CFO Jeffrey Creech and new Regenerative Medicine President Harriss Currie
--------------------------------------------------------------------------------

- Jeffrey Creech joins as EVP and CFO effective Dec 13, succeeding interim CFO Andrew Johnson.
- Harriss Currie named President – Regenerative Medicine (new role) effective Dec 15.
- Creech receives $425K base salary, 60% bonus target, and $500K RSU vesting over 3 years.
- Currie to lead regenerative medicine efforts including United Therapeutics partnership and Systemic Bio.
- Andrew Johnson remains EVP, Chief Corporate Development Officer and Chief Legal Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910638/000119312523295484/0001193125-23-295484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910638/000119312523295484/d664651d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-295484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer